1-(3,5-Bis(trifluoromethyl)phenyl)-3-((1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)thiourea
97%
- Product Code: 79970
CAS:
871828-95-4
Molecular Weight: | 420.37 g./mol | Molecular Formula: | C₁₈H₁₄F₆N₂OS |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of biologically active molecules, particularly those targeting enzyme inhibition. Its structure is often explored in the design of potential therapeutic agents due to the presence of the trifluoromethyl groups, which enhance binding affinity and metabolic stability. Additionally, the thiourea moiety is significant in interactions with biological targets, making it valuable in the development of inhibitors for diseases such as cancer and infectious diseases. Its application extends to research in optimizing pharmacokinetic properties and improving drug efficacy in preclinical studies.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.050 | 10-20 days | ฿1,107.00 |
+
-
|
0.250 | 10-20 days | ฿3,312.00 |
+
-
|
1-(3,5-Bis(trifluoromethyl)phenyl)-3-((1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)thiourea
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of biologically active molecules, particularly those targeting enzyme inhibition. Its structure is often explored in the design of potential therapeutic agents due to the presence of the trifluoromethyl groups, which enhance binding affinity and metabolic stability. Additionally, the thiourea moiety is significant in interactions with biological targets, making it valuable in the development of inhibitors for diseases such as cancer and infectious diseases. Its application extends to research in optimizing pharmacokinetic properties and improving drug efficacy in preclinical studies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :